ACR Appropriateness Criteria® Resectable Pancreatic Cancer-Reference-Cited by-同舟云学术

ACR Appropriateness Criteria® Resectable Pancreatic Cancer

Published:2017-04 Issue:2 Volume:40 Page:109-117
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Jones William E.,Suh W. Waren,Abdel-Wahab May,Abrams Ross A.,Azad Nilofer,Das Prajnan,Dragovic Jadranka,Goodman Karyn A.,Jabbour Salma K.,Konski Andre A.,Koong Albert C.,Kumar Rachit,Lee Percy,Pawlik Timothy M.,Small William,Herman Joseph M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference77 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States);Cress;Cancer Causes Control,2006

3. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients;Narimatsu;Cancer Res,1998

4. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy;Hartwig;Ann Surg Oncol,2013

5. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer;Kinsella;Am J Clin Oncol,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implication of extra-pancreatic organ invasion in resectable pancreas ductal adenocarcinoma in the pancreas tail;European Journal of Radiology;2024-12

2. Management of Primary Pancreatic Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23

3. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation;Cell Death & Disease;2020-10

4. Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score;Radiology;2020-09

5. Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers;Clinical Cancer Research;2018-09-28